Ramona Meister
Dr.
Ramona Meister
M. Sc.
  • Wissenschaftliche Mitarbeiterin
Arbeitsbereich

Kontakt

Standort

W26 , 2. Etage
Sprachen
Deutsch (Muttersprache)

Tätigkeitsschwerpunkte

Publikationen

2019

Comparative effectiveness of continuation and maintenance treatments for persistent depressive disorder in adults
Machmutow K, Meister R, Jansen A, Kriston L, Watzke B, Härter M, Liebherz S
COCHRANE DB SYST REV. 2019;5:CD012855.

Non-concealed placebo treatment for menopausal hot flushes: Study protocol of a randomized-controlled trial
Pan Y, Meister R, Löwe B, Winkelmann A, Kaptchuk T, Bühling K, Nestoriuc Y
TRIALS. 2019;20(1):508.

Effectiveness of metacognitive interventions for mental disorders in adults-A systematic review and meta-analysis (METACOG)
Philipp R, Kriston L, Lanio J, Kühne F, Härter M, Moritz S, Meister R
CLIN PSYCHOL PSYCHOT. 2019;26(2):227-240.

Two-Year Follow-Up after Treatment with the Cognitive Behavioral Analysis System of Psychotherapy versus Supportive Psychotherapy for Early-Onset Chronic Depression
Schramm E, Kriston L, Elsaesser M, Fangmeier T, Meister R, Bausch P, Zobel I, Bailer J, Wambach K, Backenstrass M, Klein J, Schoepf D, Schnell K, Gumz A, Löwe B, Walter H, Wolf M, Domschke K, Berger M, Hautzinger M, Härter M
PSYCHOTHER PSYCHOSOM. 2019;88(3):154-164.

2018

Psychotherapie depressiver Störungen: Evidenz bei chronischer Depression und bei Komorbidität
Härter M, Jansen A, Berger M, Baumeister H, Bschor T, Harfst T, Hautzinger M, Kriston L, Kühner C, Schauenburg H, Schorr S, Schneider F, Meister R
NERVENARZT. 2018;89(3):252-262.

How often do general practitioners use placebos and non-specific interventions? Systematic review and meta-analysis of surveys
Linde K, Atmann O, Meissner K, Schneider A, Meister R, Kriston L, Werner C
PLOS ONE. 2018;13(8):e0202211.

Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis
Meister R, Abbas M, Antel J, Peters T, Pan Y, Bingel U, Nestoriuc Y, Hebebrand J
EUR CHILD ADOLES PSY. 2018.

Psychotherapie depressiver Störungen. Verfahren, Evidenz und Perspektiven
Meister R, Jansen A, Berger M, Baumeister H, Bschor T, Harfst T, Hautzinger M, Kriston L, Kühner C, Schauenburg H, Schorr S, Schneider F, Härter M
NERVENARZT. 2018;89(3):241-251.

2017

Patient involvement in a systematic review: Development and pilot evaluation of a patient workshop
Brütt A, Meister R, Bernges T, Moritz S, Härter M, Kriston L, Kühne F
ZEFQ Z Evidenz Fortbild Qual G. 2017;127-128:56-61.

Effectiveness of metacognitive interventions for mental disorders in adults: a systematic review protocol (METACOG)
Kühne F, Meister R, Jansen A, Härter M, Moritz S, Kriston L
BMJ OPEN. 2017;7(6):e015428.

Continuation and maintenance treatments for persistent depressive disorder
Liebherz S, Machmutow K, Jansen A, Meister R, Watzke B, Härter M, Kriston L
COCHRANE DB SYST REV. 2017;2017(11):CD012855.

Placebo and nocebo reactions in randomized trials of pharmacological treatments for persistent depressive disorder. A meta-regression analysis
Meister R, Jansen A, Härter M, Nestoriuc Y, Kriston L
J AFFECT DISORDERS. 2017;215:288-298.

Effect of Disorder-Specific vs Nonspecific Psychotherapy for Chronic Depression: A Randomized Clinical Trial
Schramm E, Kriston L, Zobel I, Bailer J, Wambach K, Backenstrass M, Klein J, Schoepf D, Schnell K, Gumz A, Bausch P, Fangmeier T, Meister R, Berger M, Hautzinger M, Härter M
JAMA PSYCHIATRY. 2017;74(3):233-242.

2016

Psychotherapie bei Depressionen: Aktuelle Empfehlungen der revidierten Fassung der Nationale Versorgungsleitlinie Depression
Hautzinger M, Berger M, Bräunlich I, Bschor T, Gensichen J, Harfst T, Jansen, geb. von Wolff A, Kühner C, Kriston L, Leucht S, Matzat J, Meister R, Nothacker M, Richter R, Schauenburg H, Schulz H, Schorr S, Schneider F, Härter M
Z Klin Psychol Psychother (Gott). 2016;46(2):85-92, Erratum in 2016; 45 (4): 290.

Comparative Safety of Pharmacologic Treatments for Persistent Depressive Disorder: A Systematic Review and Network Meta-Analysis
Meister R, von Wolff A, Mohr H, Härter M, Nestoriuc Y, Hölzel L, Kriston L
PLOS ONE. 2016;11(5):e0153380.

Adverse event methods were heterogeneous and insufficiently reported in randomized trials on persistent depressive disorder
Meister R, von Wolff A, Mohr H, Nestoriuc Y, Härter M, Hölzel L, Kriston L
J CLIN EPIDEMIOL. 2016;71:97-108.

Treatment patterns in inpatient depression care
von Wolff A, Meister R, Härter M, Kriston L
INT J METH PSYCH RES. 2016;25(1):55-67.

2015

Effectiveness of a brief psychoeducational group intervention for relatives on the course of disease in patients after inpatient depression treatment compared with treatment as usual - study protocol of a multisite randomised controlled trial
Frank F, Wilk J, Kriston L, Meister R, Shimodera S, Hesse K, Bitzer E, Berger M, Hölzel L
BMC PSYCHIATRY. 2015;15(1):259.

Odds ratios of treatment response were well approximated from continuous rating scale scores for meta-analysis
Meister R, von Wolff A, Kriston L
J CLIN EPIDEMIOL. 2015;68(7):740-51.

2014

Incorporating uncertainty regarding applicability of evidence from meta-analyses into clinical decision making
Kriston L, Meister R
J CLIN EPIDEMIOL. 2014;67(3):325-34.

Letzte Aktualisierung aus dem FIS: 14.12.2019 - 00:36 Uhr